Tesamorelin is a growth hormone-releasing hormone analogue used in studies of the GHRH–GH–IGF axis and regional fat metabolism. Select your format and quantity for pricing, batch availability and lead time.
CAS
218949-48-5
Purity
>99%
Form
Lyophilized powder
Select a pack
3 options
Specification
5 mg / vial
Sales unit
box
Packaging
10 vials / box
Selected SKUTSM5
Minimum listed format shown. Refer to the selected SKU specifications; final packaging is confirmed with your quotation.
Test method: HPLC. Catalogue specification. Confirm the supplied batch against its COA.
Price, batch and delivery terms confirmed with your quotation.
✓ Batch-linked records✓ Private-label support✓ Multiple formats✓ Research use only
ABOUT THE MATERIAL
Product overview
Identity, scientific context and the details that distinguish this entry.
Tesamorelin is a growth hormone-releasing hormone analogue used in studies of the GHRH–GH–IGF axis and regional fat metabolism.[Sources]
It acts within the releasing-hormone pathway upstream of GH secretion. The linked clinical investigation measured visceral and liver fat as separate endpoints in people with HIV-associated abdominal fat accumulation.
Research variables
The cited trial distinguished visceral adipose tissue, liver fat and glucose-related measurements. These endpoints describe different metabolic compartments and should be retained separately when interpreting results.
A CLOSER LOOK
Mechanisms & published research
Read each finding with its study model and material identity.
01
A population-specific fat-distribution endpoint
The randomized trial enrolled people with HIV-associated abdominal fat accumulation. Visceral adipose tissue and liver fat were measured separately, alongside glucose-related endpoints. The study illustrates the importance of regional fat measurements and a clearly defined population when interpreting GHRH-axis research.
Match the offered lot number, identity, test methods and reported results.
02
HPLC / MS records
Ask for available chromatograms and mass-identity records, including the method and reporting scope.
03
SDS & storage information
Confirm handling, transport and storage information for the offered material and packaging.
A document request adds no purchase quantity. Have a batch reference? Open batch records ↗
BEFORE YOU ENQUIRE
Common questions
Which metabolic endpoints were studied?
The cited trial distinguished visceral adipose tissue, liver fat and glucose-related measurements. These endpoints describe different metabolic compartments and should be retained separately when interpreting results.
How should storage and handling be confirmed?
Use the specification and available safety or stability information for the offered lot, form and packaging. Request written conditions before ordering; literature alone does not establish a universal temperature, shelf life or reconstitution procedure.
How are catalogue specifications checked against a batch?
The displayed value is a catalogue specification. Assess the offered lot against its matching COA and method. Chromatographic purity, component content and biological activity are different measurements; confirm which results are available.
What information helps with a quotation?
Include the exact SKU, quantity in boxes, destination, desired timing and document requirements. State any label or packaging needs. Pricing, availability, lead time and document scope are confirmed in the quotation.
Stanley TL, Feldpausch MN, Oh J, Branch KL, Lee H, Torriani M, Grinspoon SK. 2014, DOI: 10.1001/jama.2014.8334
Randomized trial in 50 people with HIV
Publications describe their own study materials and methods. They are distinct from BatchTide specifications and lot-release records. Materials listed here are for laboratory research only, not for human or veterinary use.
EXPLORE THE CATALOGUE
Related research materials
Explore related entries. Similar research contexts do not establish interchangeability.